Skip to main content
AIMD
NASDAQ Technology

Ainos Proxy Seeks Approval for 3M Special Stock Awards and ASE Note Conversion Above 20%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.469
Mkt Cap
$3.465M
52W Low
$0.463
52W High
$3.88
52W Position info
1.5% above low
Off High info
88% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

AIMD is trading near its 52-week low of $0.463 (1.5% above the low).

Summary

Ainos' definitive proxy asks shareholders to approve up to 3,000,000 special stock awards and to let ASE Test convert its $11M of notes past the 20% Nasdaq threshold — both meaningfully dilutive, both framed as necessary given going-concern pressure.


Key Events · Corporate Governance and Compliance · AIMD

  • Annual Meeting Set for December 24

    A definitive proxy filed November 10, 2026 sets the meeting for 5:30 p.m. Taiwan time on December 24, 2026; the record date is October 27, 2026, with 8,717,125 shares outstanding and entitled to vote.

  • 3,000,000 Special Stock Awards Proposed

    Proposal 3 seeks approval to reserve up to 3,000,000 shares as special stock awards outside the 2023 Stock Incentive Plan under Nasdaq Rule 5635(c) — roughly a third of the 8,717,125 shares currently outstanding if fully granted.

  • ASE Test Conversion Above 20% Threshold

    Proposal 5 would let ASE Test convert its $2,000,000 (2023) and $9,000,000 (May 3, 2024) 6% notes past the Nasdaq cap; 20% of the current base equals approximately 1,743,425 shares, and ASE Test already holds 667,085 shares (7.12%).

  • Rejection Means Cash Repayment in 2027

    Without approval the company cannot issue conversion shares above the Exchange Cap and would have to repay the notes in cash at their March 12, 2027 and May 3, 2027 maturities — funds it may not have, per the going-concern disclosure in the June 30, 2026 10-Q.


Analysis · AIMD · Technology

Two of the five proposals go directly to share count. Proposal 3 asks holders to reserve up to 3,000,000 shares as special stock awards outside the 2023 plan — against 8,717,125 shares outstanding, that is roughly a third of the current base if fully granted. Proposal 5 asks holders to waive the Nasdaq 20% cap so ASE Test can convert its $2.0M and $9.0M 6% notes into stock; 20% of the current base is about 1,743,425 shares, and approval would make ASE Test the largest holder. Management frames conversion as debt relief it may not otherwise be able to pay in cash at the 2027 maturities, against a going-concern warning already disclosed in the June 30, 2026 10-Q. Rejection means the notes stay outstanding and the company must find cash. The meeting is December 24, 2026; the vote outcome is the next hard data point.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AIMD was trading at $0.47 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.46 to $3.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AIMD - Latest Insights

AIMD
Sep 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.39
Real-time Price: $0.4501 info
Change: -$0.9379 (-68%) info
Market Cap: $3.324M info
AIMD
Sep 28, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $1.32
Real-time Price: $0.4501 info
Change: -$0.8699 (-66%) info
Market Cap: $3.324M info
AIMD
Sep 24, 2026, 8:00 AM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $0.4501 info
Change: -$1.05 (-70%) info
Market Cap: $3.324M info
AIMD
Sep 16, 2026, 11:00 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $1.37
Real-time Price: $0.4501 info
Change: -$0.9199 (-67%) info
Market Cap: $3.324M info
AIMD
Sep 14, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $0.4501 info
Change: -$1.05 (-70%) info
Market Cap: $3.324M info